文献速递自身免疫性与大疱性皮肤病

皮肌炎中的瘙痒:皮肤白细胞介素-31增加的作用

Itch in dermatomyositis: the role of increased skin interleukin-31.
PubMed 文献 · Br J Dermatol · 2018-06-21

研究评估191例皮肌炎患者瘙痒患病率及IL-31在皮肌炎相关瘙痒中的作用。50.8%患者有中重度瘙痒,瘙痒与皮肤严重度相关(r=0.34);皮损皮肤IL31及IL31RA表达上调,IL31 mRNA与VAS瘙痒评分正相关(r=0.67),CD4+细胞是主要IL-31来源细胞;Lenabasum可下调CpG刺激PBMC的IL-31。

要点

  • 191例皮肌炎患者中50.8%有中重度瘙痒,瘙痒与皮肤严重度相关(r=0.34)。
  • 皮损皮肤IL31及IL31RA表达较非皮损和健康对照皮肤上调,IL31 mRNA与VAS瘙痒评分正相关(r=0.67)。
  • 皮损皮肤IL-31产生细胞显著增多,CD4+细胞为最常见细胞类型;Lenabasum显著下调CpG刺激PBMC的IL-31。

核心结论

  • 皮肤IL-31增加可能在皮肌炎相关瘙痒中起作用,正在进行的试验将评估全身治疗对皮肌炎中IL-31和瘙痒的影响。

研究设计与样本

  • 评估191例皮肌炎患者的瘙痒与疾病活动度,分别采用视觉模拟评分(VAS)和皮肤疾病活动与严重度指数(CDASI)。
  • 采用定量逆转录聚合酶链反应和免疫荧光评估皮肌炎皮损、非皮损及健康对照皮肤中IL-31和IL-31受体α(IL-31RA)的表达。
  • 对从皮肌炎皮损皮肤分离的皮肤细胞进行流式细胞术,以鉴定皮肌炎中IL-31的细胞来源。

主要发现

  • 191例皮肌炎患者中50.8%有中重度瘙痒,瘙痒与皮肤严重度增加相关(r=0.34)。
  • 在瘙痒性皮肌炎患者中,皮损皮肤IL31和IL31RA基因表达较非皮损皮肤和健康对照皮肤上调。
  • IL31 mRNA表达与VAS瘙痒评分正相关(r=0.67)。
  • 免疫荧光显示皮损皮肤中IL-31和IL-31RA免疫反应性更强。
  • 流式细胞术显示皮损皮肌炎皮肤含显著更多的IL-31产生细胞,CD4+细胞为最常见细胞类型;Lenabasum显著下调CpG刺激外周血单核细胞的IL-31。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interleukin (IL)-31 is implicated in pruritus associated with pruritic skin diseases like atopic dermatitis. Although pruritus is a prominent feature in dermatomyositis (DM), few studies have evaluated the pathogenesis of DM-associated itch. OBJECTIVES: To establish the prevalence of itch in DM, and to investigate the role of IL-31 in DM-related itch. METHODS: Pruritus and disease activity of DM were evaluated by a visual analogue scale (VAS) and the Cutaneous Disease and Activity Severity Index (CDASI), respectively. Expression of IL-31 and IL-31 receptor alpha (IL-31RA) in lesional DM, nonlesional DM and healthy control skin was evaluated by quantitative reverse-transcriptase polymerase chain reaction and immunofluorescence. Flow cytometry was performed on skin cells isolated from lesional DM skin to identify cellular sources of IL-31 in DM. RESULTS: Among 191 patients with DM, 50·8% had moderate-to-severe itch, and itch was correlated with increased cutaneous severity (r = 0·34). In patients with itchy DM, gene expression of IL31 and IL31RA in lesional skin was upregulated compared with nonlesional skin and healthy control skin. IL31 mRNA expression positively correlated with VAS itch score (r = 0·67). On immunofluorescence, immunoreactivity for IL-31 and IL-31RA was stronger in lesional skin. Flow cytometry showed that lesional DM skin contained significantly more IL-31-producing cells, and CD4+ cells were the most common cell type. Lenabasum, an emerging treatment for DM, significantly downregulated IL-31 from CpG-stimulated peripheral blood mononuclear cells. CONCLUSIONS: Increased skin IL-31 may play a role in DM-associated itch, and ongoing trials will evaluate the effects of systemic treatment on IL-31 and itch in DM.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Kim HJ, Zeidi M, Bonciani D, et al. Itch in dermatomyositis: the role of increased skin interleukin-31. Br J Dermatol. 2018. PMID: 29494763. doi:10.1111/bjd.16498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。